A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...

A study has found that a women’s risk of developing dementia may be predicted 25 years before symptoms begin through a test of a blood-based biomarker ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Researchers led by a scientist at UC San Diego examined blood samples collected in the 1990s to detect a key biomarker’s presence.

A retinal image could help doctors quickly distinguish between similar neurodegenerative diseases, such as ALS and Alzheimer's disease, and with remarkable accuracy, according to new research ...

Past research has linked Alzheimer's disease to problems with the chemical channels that produce energy in brain cells. One ...

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

Scientists develop a blood test that detects Alzheimer’s by measuring protein structural changes rather than protein quantity.

Dementia is one of the biggest health challenges facing aging populations around the world. Millions of people develop memory loss and thinking problems as they grow older, and Alzheimer’s disease is ...

UC San Diego researchers found a blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms.